multidrug resistant tb (mdr tb)

What are the Treatment Options for MDR TB in Children?

Treating MDR TB in children is complex and requires a combination of second-line drugs, which may include:
Fluoroquinolones
Injectable agents (e.g., amikacin, capreomycin)
Newer drugs like bedaquiline and delamanid
The treatment duration is typically longer, often 18-24 months, and involves close monitoring for adverse effects and treatment adherence.

Frequently asked queries:

What is Multidrug Resistant TB (MDR TB)?
How Common is MDR TB in Children?
What are the Risk Factors for MDR TB in Children?
What are the Symptoms of MDR TB in Children?
How is MDR TB Diagnosed in Children?
What are the Treatment Options for MDR TB in Children?
What are the Challenges in Treating MDR TB in Children?
How Can MDR TB in Children be Prevented?
What is the Role of Healthcare Providers in Managing MDR TB in Children?
How Do Pragmatic Skills Develop in Children?
What Are Pediatric Blockages?
When is it Appropriate to Remove a Penrose Drain?
How Often Should Children Have Health Check-ups?
Why is Quality Time Important in Pediatrics?
What is the Prognosis for Infants with Biliary Atresia?
What are the Limitations of Palivizumab?
Can Nuchal Cord be Prevented?
What Are the Recommended Sugar Intake Levels for Children?
How does SHIN-NY improve care coordination for pediatric patients?
What Causes ODD?
Follow Us
Top Searches
Nasal Obstruction Neonatal Disorders Neonatal sepsis Pediatric Anemia Pediatric Cardiovascular Diseases Pediatric Epilepsy

Partnered Content Networks

Relevant Topics